EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering the antifungal potential of Cannabidiol and Cannabidivarin

Hue Dinh iD, Kenya E Fernandes, Paige E Erpf, Evie J M Clay, Aidan P Tay, Stephanie S Nagy, Sebastian Schaefer, Ram Maharjan, Megan D Lenardon, Dylan H Multari, Paul A Haynes, Ian T Paulsen und 4 weitere

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Hue Dinh und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Natural Sciences, Macquarie University, North Ryde, New South Wales, Australia. Hauptthemen laut MEDLINE: Antifungal Agents, Cannabidiol, Cryptococcus neoformans, Cannabinoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macquarie University Research Acceleration Scheme, Australian Research Council Industrial Transformation Training Centre for Facilitated Advancement of Australia’s Bioactives, International Cotutelle Macquarie Excellence Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections pose a major threat to human health with increasing incidence of antifungal resistance globally. Despite the need for novel antifungal drugs, few are currently in clinical development. Here we evaluate the antifungal activity of five phytocannabinoids against several clinically relevant fungal pathogens, with a focus on the priority pathogen Cryptococcus neoformans . Our results demonstrate that Cannabidiol (CBD), and particularly Cannabidivarin (CBDV), have broad activity against C. neoformans and other fungal pathogens, including dermatophytes that cause common tinea. We found that both CBD and CBDV acted in a fungicidal manner and prevented biofilm formation in C. neoformans . Phytocannabinoid treatment impeded factors important for virulence and antifungal resistance, including reduced capsule size and disruption of mature biofilms. Proteomics analysis revealed that the antifungal activity of CBD and CBDV was linked to destabilisation of the membrane, alterations in ergosterol biosynthesis, disruption of metabolic pathways, as well as selective involvement of mitochondrial-associated proteins. We next tested the ability of CBD to topically clear a C. neoformans fungal infection in vivo using the Galleria mellonella burn wound model, and we observed greatly improved survival in the CBD treated larvae. This study illustrates the potential of phytocannabinoids as antifungal treatments and opens up new routes towards development of novel antifungal drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCannabidiolCryptococcus neoformansCannabinoidsAnimalsBiofilmsMicrobial Sensitivity TestsCryptococcosisHumansDisease Models, AnimalProteomics

Substanzen

Antifungal AgentsCannabidiolCannabinoids

Autor:innen und Institutionen

  • School of Natural Sciences, Macquarie University, North Ryde, New South Wales, Australia.
  • ARC Centre of Excellence in Synthetic Biology, School of Natural Sciences, Macquarie University, North Ryde, New South Wales, Australia.
  • School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia.
  • Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.
  • School of Biological Sciences, University of Bristol, Bristol, United Kingdom.
  • School of Biotechnology and Biomolecular Sciences, UNSW, Sydney, New South Wales, Australia.

ORCID-Profile: Hue Dinh, Amy K Cain

Förderung

  • Macquarie University Research Acceleration Scheme
  • Australian Research Council Industrial Transformation Training Centre for Facilitated Advancement of Australia’s Bioactives
  • International Cotutelle Macquarie Excellence Scholarship
  • Macquarie University
  • Australian Research Council

Zitieren

APA

Dinh, H., Fernandes, K. E., Erpf, P. E., Clay, E. J. M., Tay, A. P., Nagy, S. S., Schaefer, S., Maharjan, R., Lenardon, M. D., Multari, D. H., Haynes, P. A., Paulsen, I. T., Santiago, M. J., Connor, M., Carter, D., & Cain, A. K. (2025). Uncovering the antifungal potential of Cannabidiol and Cannabidivarin. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013081

Vancouver

Dinh H, Fernandes KE, Erpf PE, Clay EJM, Tay AP, Nagy SS, et al. Uncovering the antifungal potential of Cannabidiol and Cannabidivarin. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013081

BibTeX
@article{Dinh2025,
  author = {Dinh, Hue and Fernandes, Kenya E and Erpf, Paige E and Clay, Evie J M and Tay, Aidan P and Nagy, Stephanie S and Schaefer, Sebastian and Maharjan, Ram and Lenardon, Megan D and Multari, Dylan H and Haynes, Paul A and Paulsen, Ian T and Santiago, Marina J and Connor, Mark and Carter, Dee and Cain, Amy K},
  title = {Uncovering the antifungal potential of Cannabidiol and Cannabidivarin},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013081}
}
Kostenlos starten →